Ngā hua rapu - Levi A. Garraway

Whakamahine hua
  1. 1
    Lessons from the Cancer Genome

    Lessons from the Cancer Genome mā Levi A. Garraway, Eric S. Lander

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Circumventing Cancer Drug Resistance in the Era of Personalized Medicine

    Circumventing Cancer Drug Resistance in the Era of Personalized Medicine mā Levi A. Garraway, Pasi A. Jänne

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    The genomic landscape of prostate cancer

    The genomic landscape of prostate cancer mā Sylvan C. Baca, Levi A. Garraway

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Clinical Implications of the Cancer Genome

    Clinical Implications of the Cancer Genome mā Laura E. MacConaill, Levi A. Garraway

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Malignant melanoma: genetics and therapeutics in the genomic era

    Malignant melanoma: genetics and therapeutics in the genomic era mā Lynda Chin, Levi A. Garraway, David E. Fisher

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Precision Oncology: An Overview

    Precision Oncology: An Overview mā Levi A. Garraway, Jaap Verweij, Karla V. Ballman

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    A Convergence-Based Framework for Cancer Drug Resistance

    A Convergence-Based Framework for Cancer Drug Resistance mā David J. Konieczkowski, Cory M. Johannessen, Levi A. Garraway

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Melanoma: from mutations to medicine

    Melanoma: from mutations to medicine mā Hensin Tsao, Lynda Chin, Levi A. Garraway, David E. Fisher

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Long-term drug administration in the adult zebrafish using oral gavage for cancer preclinical studies

    Long-term drug administration in the adult zebrafish using oral gavage for cancer preclinical studies mā Michelle Dang, Rachel E. Henderson, Levi A. Garraway, Leonard I. Zon

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The role(s) of lipophosphoglycan (LPG) in the establishment of<i>Leishmania major</i>infections in mammalian hosts

    The role(s) of lipophosphoglycan (LPG) in the establishment of<i>Leishmania major</i>infections in mammalian hosts mā Gérald F. Späth, Levi A. Garraway, Salvatore J. Turco, Stephen M. Beverley

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors

    ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors mā Eva M. Goetz, Mahmoud Ghandi, Daniel J. Treacy, Nikhil Wagle, Levi A. Garraway

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania.

    Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania. mā Kathleen A. Ryan, Levi A. Garraway, Albert Descoteaux, S J Turco, Stephen M. Beverley

    I whakaputaina 1993
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    gkmSVM: an R package for gapped-kmer SVM

    gkmSVM: an R package for gapped-kmer SVM mā Mahmoud Ghandi, Morteza Mohammad-Noori, Narges Ghareghani, Dongwon Lee, Levi A. Garraway, M Beer

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors

    Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors mā Steven R. Whittaker, Glenn S. Cowley, Steve Wagner, Flora Luo, David E. Root, Levi A. Garraway

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation

    Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation mā Asaf Rotem, Andreas Janzer, Benjamin Izar, Zhe Ji, John G. Doench, Levi A. Garraway, Kevin Struhl

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Highly Recurrent <i>TERT</i> Promoter Mutations in Human Melanoma

    Highly Recurrent <i>TERT</i> Promoter Mutations in Human Melanoma mā Franklin W. Huang, Eran Hodis, Mary Jue Xu, Gregory V. Kryukov, Lynda Chin, Levi A. Garraway

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Attitudes of Patients With Cancer About Personalized Medicine and Somatic Genetic Testing

    Attitudes of Patients With Cancer About Personalized Medicine and Somatic Genetic Testing mā Stacy W. Gray, Katherine Hicks-Courant, Christopher S. Lathan, Levi A. Garraway, Elyse R. Park, Jane C. Weeks

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines

    SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines mā Francesca Demichelis, Heidi Greulich, Jill A. Macoska, Rameen Beroukhim, William R. Sellers, Levi A. Garraway, Mark A. Rubin

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    High‐throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide‐3‐kinase and other oncogenes

    High‐throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide‐3‐kinase and other oncogenes mā Edwin Choy, Francis J. Hornicek, Laura E. MacConaill, David C. Harmon, Zeeshan Tariq, Levi A. Garraway, Zhenfeng Duan

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    p85 Associates with Unphosphorylated PTEN and the PTEN-Associated Complex

    p85 Associates with Unphosphorylated PTEN and the PTEN-Associated Complex mā Rosalia Rabinovsky, Panisa Pochanard, Chontelle J. McNear, Saskia M. Brachmann, Jonathan S. Duke‐Cohan, Levi A. Garraway, William R. Sellers

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: